Cannabis Hyperemesis Syndrome: Treatment and Risks of Heavy Marijuana Use
Cannabis consumption is surging among teens and young adults, but a key question remains: are clients and families truly educated about the risks of long-term consumption?
In a new, expert article by The Dorm and R&A Therapeutic Partners, two long-time mental health experts share what they are seeing on the front lines of treatment including striking cases of Cannabis Hyperemesis Syndrome (CHS), cannabis-induced psychosis, and lasting cognitive functioning deficits.
This article on Cannabis Hyperemesis Syndrome covers:
- What CHS is, how it presents and is diagnosed, and how difficult it is to treat
- How long-term marijuana use is presenting in young adults today and the multi-faceted mental health ramifications
- The opportunities for improved family education and support around heavy marijuana use and sustained treatment
Authors and Mental Health Experts:
- Robert L. Johnson MC, MCAP, LPC – Director The Dorm, Washington, D.C.
- Ray Estefania, MS, LMHC, CAP, CIP – R&A Therapeutic Partners
About R&A Therapeutic Partners
Ana Moreno, LMHC, MCAP, CIP, CAI, ICADC, CDWF and Ray Estefania, MS, LMHC, CAP, CIP, ICADC of R&A Therapeutic Partners offer interventions and educational/therapeutic consulting services to those suffering from mental health disorders as well as problems with substances and process addictions.
About The Dorm
Since 2009, The Dorm’s mission has been to guide young adults ages 17 to 35 towards greater personal independence through our full-service treatment community with locations on the Upper West Side of New York City and at Dupont Circle in Washington, D.C.